New approach for the discovery of novel dual-target human monoamine oxidase B (hMAO-B) and cholinesterase enzymes (acetylcholinesterase and butyrylcholinesterase, AChE and BChE) inhibitors and their evaluation in neurodegenerative disorders
New approach for the discovery of novel dual-target human monoamine oxidase B (hMAO-B) and cholinesterase enzymes (acetylcholinesterase and butyrylcholinesterase, AChE and BChE) inhibitors and their evaluation in neurodegenerative disorders